CÁNCER DE MAMA
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (20)
2019
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Therapeutic Advances in Medical Oncology, Vol. 11
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
International Journal of Colorectal Disease, Vol. 33, Núm. 2, pp. 241-249
-
The Spanish Society of Cytology: Quality control program of gynecological cytology
Revista Espanola de Patologia, Vol. 51, Núm. 2, pp. 71-76
2017
-
Predictive and prognostic brain metastases assessment in luminal breast cancer patients: FN14 and GRP94 from diagnosis to prophylaxis
Frontiers in Oncology, Vol. 7, Núm. DEC
-
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1392-1407
2016
-
Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry
Journal of Pharmaceutical and Biomedical Analysis, Vol. 117, pp. 140-149
2015
-
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
Oncotarget, Vol. 6, Núm. 42, pp. 44254-44273
2014
-
VAV3 mediates resistance to breast cancer endocrine therapy
Breast Cancer Research, Vol. 16, Núm. 3
2013
-
Basal/HER2 breast carcinomas Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)
Cell Cycle, Vol. 12, Núm. 2, pp. 225-245
2012
-
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment
Oncotarget, Vol. 3, Núm. 12, pp. 1600-1614
-
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
Breast Cancer Research and Treatment, Vol. 134, Núm. 3, pp. 1161-1168
-
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis
Cancer Research, Vol. 72, Núm. 11, pp. 2879-2888
2011
-
Evidence for a link between TNFRSF11A and risk of breast cancer
Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954
2010
-
Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women
Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 6, pp. 289-292
2009
-
Removal of the internal mammary sentinel node in breast cancer
Nuclear Medicine Communications, Vol. 30, Núm. 12, pp. 962-970
2004
-
Treatment of malignant superior vena cava syndrome by endovascular stent insertion: Experience on 52 patients with lung cancer
Lung Cancer, Vol. 43, Núm. 2, pp. 209-214